List view / Grid view

Timothy Maloney

 

news

Novartis drug Galvus® approved in EU

The European Commission has approved Galvus® (vildagliptin) (50 mg once…

5 December 2011 | By Novartis

The European Commission has approved Galvus® (vildagliptin) (50 mg once a day) for the treatment of type 2 diabetes patients with moderate or severe renal impairment...